COMP <GO>
OPCH vs LFST // EV/EBITDA & P/E VALUATION
Option Care Health Inc. (NASDAQ) VS. LifeStance Health Group Inc. (NASDAQ) • 15-METRIC TALLY: OPCH 6
— LFST 4
▲ EV/EBITDA & P/E VALUATION LEADER: OPCH
LAST: $31.85 (+1.79%) • MKT CAP: $4.77B
valuation
15.3x
LAST: $13.64 (+1.83%) • MKT CAP: $5.21B
valuation
95.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OPCH VS. LFST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OPCH | LFST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 19.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.90% | 1.20% | +10.70 | OPCH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.3x | 95.3x | -80.00 | OPCH | /valuation <GO> |
| Free Cash Flow Yield | 4.55% | 2.11% | +2.44 | OPCH | /fcf-yield <GO> |
| Operating Margin | 6.00% | 1.70% | +4.30 | OPCH | /operating-margins <GO> |
| Net Profit Margin | 3.70% | 0.70% | +3.00 | OPCH | /net-margins <GO> |
| Revenue Growth (YoY) | 13.00% | 13.90% | -0.90 | LFST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.81 | 4.84 | -1.03 | LFST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | LFST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 84.3 | 64.8 | +19.54 | OPCH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.77B | $5.21B | -$440.0M | LFST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OPCH REV | LFST REV | OPCH GROSS % | LFST GROSS % | OPCH FCF | LFST FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.65B | $1.42B | 19.3% | — | $217.1M | $110.0M |
| FY 2024 | $5.00B | $1.25B | 20.3% | — | $287.8M | $85.7M |
| FY 2023 | $4.30B | $1.06B | — | — | $177.7M | -$16.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OPCH // BETA 1.10
LFST // BETA —